Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD22 underexpression + BCL2 overexpression
i
Other names:
CD22, CD22 Molecule, CD22 Antigen, SIGLEC2, Sialic Acid-Binding Ig-Like Lectin 2, B-Lymphocyte Cell Adhesion Molecule, T-Cell Surface Antigen Leu-14, B-Cell Receptor CD22, SIGLEC-2, BL-CAM, Sialic Acid Binding Ig-Like Lectin 2, Siglec-2, BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
596
;
933
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
BCL2 amplification (1)
BCL2 amplification (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CD22 underexpression + BCL2 overexpression
Acute Lymphocytic Leukemia
CD22 underexpression + BCL2 overexpression
Acute Lymphocytic Leukemia
inotuzumab ozogamicin
Resistant: C3 – Early Trials
inotuzumab ozogamicin
Resistant
:
C3
inotuzumab ozogamicin
Resistant: C3 – Early Trials
inotuzumab ozogamicin
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.